تنظيم مقدار دارو در نارسائيهاي کبدي
|
درصد دوز |
مقدار بلروبين |
نام دارو |
|
75 |
1.2-3.0 mg% |
Daunorubicin |
|
50 |
>3.0 mg% |
|
|
50 |
1.5-3.0 mg% |
Doxorubicin |
|
25 |
>3.0 mg% |
|
|
50 |
2.6-5.0 mg% |
Idarubicin |
|
none |
>5.0 mg% |
|
|
100 |
1.3-3.4 mg% |
Mitoxantrone |
|
75 |
>3.4 mg% |
|
|
50 |
1.5 mg% |
Vinblastine |
|
25 |
>3.0 mg% |
|
|
50 |
1.5 mg% |
Vincristine |
|
25 |
>3.0 mg% |
|
|
Source: Legha SS, et al: Cancer 38-27-35L 1976). |
|
Alberts DS, et al: Cancer Chemother Pharmacol 1:177-181(1978). |
|
CalvertAH, et al: Cancer Chemother Pharmacol 9:140-147 (1982). |
|
DeVita VT, et al: Clin Pharmocal. Ther 8:566-577 (1967). |
|
Belt RJ, et al: Cancer Treat Rep 63:1515-1521 (1979). |
|
Bagley CM, et al: Cancer Res 33:226-233 (1973). |
|
Arbuck SG, et al: J Clin Oncol 4:1690-1695 (1986). |
|
Balis FM, et al: Cancer Res 43:2342-2345 (1983). |
|
Malspeis L, et al: Cancer Treat Symp 2:7-15 (1984). |
|
Schein PS, et al: Cancer 34:993-1000 (1974). |